Card image cap

Maggie Hassan's Public Statements on Issue: Drugs

Office:
1

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 17
Date Title
10/19/2023 Thune, Hassan, Blackburn Introduce the SAVE IMD Options Act
11/04/2022 Following Push from Senator Hassan, Administration Expands Opioid Treatment Options By Telehealth
07/26/2022 Senator Hassan Pushes to Address Fentanyl Overdoses & Substance Misuse During Senate Hearing
07/25/2022 Letter to Hon. Robert M. Califf, Commissioner of the FDA - Senator Baldwin Voices Support for FDA's Proposed "Life-Saving" Ban on Menthol Cigarettes and Flavored Cigars
07/21/2022 Letter to Robert Califf, Commissioner of the Food and Drug Administration - Senators Hassan and Paul Press FDA to Increase Access to Life-Saving Naloxone
05/06/2022 Feinstein, Grassley, Colleagues Seek to Deter Counterfeit Pill Production
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/16/2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
02/25/2022 Letter to Chuck Schumer, Senate Majority Leader, Patrick Leahy, Chair of the Senate Appropriations Committee, Chris Murphy, Chair of the Senate Subcommittee on Homeland Security - Peters Calls for Robust Funding to Support DHS Border Security and Drug Detection
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
02/16/2022 Senator Hassan, Colleagues Urge DOJ to Investigate Sackler Family Members for Role in Fueling Substance Misuse Crisis
02/15/2022 Senator Hassan Votes Against Confirming FDA Commissioner Nominee, Robert Califf
12/21/2021 NH Delegation Welcomes $4.7 Million to Support Individuals & Families Impacted by Substance Use Disorders
12/20/2021 NH Delegation Welcomes $1.6 Million to Combat Substance Use Disorder Crisis through NH Drug Court Program
11/01/2021 NH Delegation Announces $1.4M to Support Drug Enforcement Efforts
10/28/2021 Senators Hassan, Toomey Introduce Bipartisan Amendment to Stop Countries From Turning a Blind Eye to Illicit Fentanyl Exports
10/23/2021 Fox News Publishes Senator Hassan's Op-Ed on National Prescription Drug Take Back Day
10/05/2021 Letter to Hon. Anne Milgram, Administrator of the Drug Enforcement Agency - Senator Hassan Calls on the DEA to Combat Rise in Counterfeit, Dangerous Drugs
09/29/2021 Senator Hassan Joins in Introducing Bipartisan Bill to Help NH Law Enforcement Better Detect Fentanyl and Protect Officers
08/23/2021 Letter to Janet Woodcock, Acting Commissioner of Food and Drug Administration - Senators Hassan, Grassley, and Whitehouse Lead Call to FDA to Provide Answers on Potential Conflicts of Interest with Consulting Firm McKinsey in Relation to Opioid Crisis
08/13/2021 Senators Hassan, Braun Introduce Bipartisan Bill to Make It Easier and Safer to Dispose of Opioids and Other Medications
08/02/2021 Senate Passes Hassan-Supported Effort to Increased Access to Substance Use Disorder Treatment in Jails and Prisons
07/27/2021 Senator Hassan Presses DHS Secretary on Vetting and Drug Interdiction Efforts, and the Need to Re-open the Canadian Border
Page 1 of 17
arrow_upward